Breaking News Instant updates and real-time market news.

ABBV

AbbVie

$114.18

1.04 (0.92%)

12:51
02/15/18
02/15
12:51
02/15/18
12:51

AbbVie raises quarterly dividend 35%, authorizes $10B stock buyback

The board of directors of AbbVie increased the company's quarterly cash dividend by 35% from 71c per share to 96c per share and authorized a new $10B stock repurchase program. The cash dividend is payable May 15, 2018 to stockholders of record at the close of business on April 13, 2018. The stock repurchase program supersedes any existing repurchase authorizations. Purchases may be made from time to time in management's discretion. The stock repurchase authorization permits shares to be repurchased in open market or private transactions, has no time limit and may be discontinued at any time.

  • 16

    Feb

  • 08

    Mar

ABBV AbbVie
$114.18

1.04 (0.92%)

01/30/18
01/30/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. AbbVie (ABBV) downgraded to Underperform from Market Perform by analyst Alex Arfaei, who said the risk/reward has "meaningfully changed" after the rise in the stock price, adding that the new focus on fundamentals beyond the benefits of tax reform suggests "significant price erosion in immunology driven by interchangeable biosimilar anti-TNFs, and lower effectiveness of the 'Rebate Trap' to block access to cheap biosimilars". 2. iRobot (IRBT) downgraded to Neutral from Buy at Sidoti by analyst Frank Camma, who cited valuation as shares approach his $98 price target. 3. Horizon Global (HZN) downgraded to Market Perform from Outperform at BMO Capital by analyst Gerrick Johnson, who said that while he still sees "strong demand in key end markets," operation execution, rising input costs, and high debt levels are concerning. The analyst added that the company may have "lost the faith of investors" after a 30% drop in the stock price following the guidance cut. 4. Yum! Brands (YUM) downgraded to Neutral from Buy at Nomura Instinet by analyst Mark Kalinowshi, who cited valuation and concerns a possible 2018 slowdown in U.S. same-store-sales. 5. Alaska Air (ALK) downgraded to Underweight from Neutral at JPMorgan by analyst Jamie Baker, who noted that the airline is the only name where he had to cut his 2019 estimates. He also believes the company "remains in the United crosshairs in San Francisco." The analyst also downgraded Southwest (LUV) to Neutral from Overweight, and said he believes better relative value exists elsewhere in the Airlines sector. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/31/18
JEFF
01/31/18
NO CHANGE
JEFF
Jefferies sees neutral impact on Biotech from State of the Union
Jefferies analyst Michael Yee sees a net neutral impact on Biotech stocks from President Trump's State of the Union speech last night. During the speech, Trump made comments about making lower drug prices a "priority" for the year, Yee tells investors in a research not titled "Drug Pricing Comments Not New or Surprising - But a Reminder of Rhetoric." The President, however, also commented on broader access to novel clinical trial drugs, Yee points out. After a "strong biotech rally" in January, the analyst assumes the sector, "at some point," will have some relative near-term pullback either on uncertainty about Trump commentary or some consolidation. Some of the analyst's Buy-rated names include AbbVie (ABBV), Amgen (AMGN), Eli Lilly (LLY) and Gilead Sciences (GILD).
02/02/18
ARGS
02/02/18
NO CHANGE
Target $145
ARGS
Buy
AbbVie price target raised to $145 from $120 at Argus
Argus analyst David Toung raised his price target on AbbVie to $145 and kept his Buy rating after a "solid" Q4 earnings report that also included a substantial boost from lower tax rates. Toung says AbbVie is likely to submit more applications for new products and expanded indications of existing drugs this year as it develops new growth drivers such as Imbruvica and Mavyret to complement the current large contribution from Humira.
02/05/18
JEFF
02/05/18
NO CHANGE
Target $25
JEFF
Hold
Acorda remains takeover candidate after competitor data, says Jefferies
Jefferies analyst Michael Yee believes the positive Phase III topline results from Acorda Therapeutics (ACOR) competitor Sunovion for APL-130277 in Parkinson's patients came in as expected. While APL-130277 data compares favorably over Inbrija's 3.92 point difference at week 12, Yee cautions to compare directly head-to-head since patient baseline characteristics could be different. Acorda remains a "reasonably likely" acquisition candidate in 2018 given its $300M-$500M-plus Parkinson's asset Inbrija, Yee tells investors in a research note. The analyst does not think Biogen (BIIB) should buy the company, but sees other potential suitors in AbbVie (ABBV), Allergan (AGN), Mitsubishi, Roche (RHHBY) and Shire (SHPG). He believes a takeover price could be north of $2B. Yee keeps a Hold rating on Acorda with a $25 price target.

TODAY'S FREE FLY STORIES

LGND

Ligand

$133.43

0.8 (0.60%)

17:04
12/18/18
12/18
17:04
12/18/18
17:04
Earnings
Ligand raises FY18 adj. EPS view to roughly $6.63 from $6.52 »

Ligand is also raising…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGND

Ligand

$133.43

0.8 (0.60%)

17:01
12/18/18
12/18
17:01
12/18/18
17:01
Earnings
Ligand sees FY19 adjusted EPS roughly $5.50 »

Sees FY19 revenue at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CFFI

C&F Financial

$48.81

-2.19 (-4.29%)

16:58
12/18/18
12/18
16:58
12/18/18
16:58
Hot Stocks
C&F Financial names Thomas Cherry CEO »

C&F Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$34.12

0.23 (0.68%)

16:50
12/18/18
12/18
16:50
12/18/18
16:50
Hot Stocks
Breaking Hot Stocks news story on Micron »

Micron reverses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 08

    Jan

16:49
12/18/18
12/18
16:49
12/18/18
16:49
General news
API crude inventories for week of December 14 »

API reports that crude…

MU

Micron

$34.12

0.23 (0.68%)

16:48
12/18/18
12/18
16:48
12/18/18
16:48
Hot Stocks
Micron says it is focused on improving cost structure »

Says some cloud customers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 08

    Jan

RBNC

Reliant Bancorp

$23.17

0.15 (0.65%)

16:46
12/18/18
12/18
16:46
12/18/18
16:46
Hot Stocks
Reliant Bancorp raises dividend 12.5% to 9c »

Reliant Bancorp, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$34.12

0.23 (0.68%)

16:46
12/18/18
12/18
16:46
12/18/18
16:46
Hot Stocks
Micron lowers FY19 DRAM industry demand growth to 16% from 20% »

Taking "decisive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 08

    Jan

ANGI

Angi Homeservices

$15.64

-0.01 (-0.06%)

16:46
12/18/18
12/18
16:46
12/18/18
16:46
Initiation
Angi Homeservices initiated  »

Angi Homeservices…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTCH

Match Group

$41.98

0.93 (2.27%)

16:42
12/18/18
12/18
16:42
12/18/18
16:42
Initiation
Match Group initiated  »

Match Group initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNFI

United Natural Foods

$10.11

-0.75 (-6.91%)

16:42
12/18/18
12/18
16:42
12/18/18
16:42
Hot Stocks
United Natural Foods announces intent to transfer listing to NYSE from Nasdaq »

United Natural Foods…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

IAC

IAC

$177.17

1.91 (1.09%)

16:39
12/18/18
12/18
16:39
12/18/18
16:39
Initiation
IAC initiated  »

IAC initiated with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWTR

Twitter

$33.73

0.31 (0.93%)

16:37
12/18/18
12/18
16:37
12/18/18
16:37
Hot Stocks
Twitter initiates IOS update giving timeline feed chronological order feature »

Twitter added a new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRMD

TORM A/S

$7.15

(0.00%)

16:37
12/18/18
12/18
16:37
12/18/18
16:37
Syndicate
Breaking Syndicate news story on TORM A/S »

TORM A/S files $250M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAGE

Sage Therapeutics

$98.74

-3.03 (-2.98%)

16:37
12/18/18
12/18
16:37
12/18/18
16:37
Syndicate
Breaking Syndicate news story on Sage Therapeutics »

Sage Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 19

    Mar

OSUR

OraSure

$11.35

-0.17 (-1.48%)

16:36
12/18/18
12/18
16:36
12/18/18
16:36
Syndicate
Breaking Syndicate news story on OraSure »

OraSure files $300M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

ADX

Adams Express

$12.81

-0.03 (-0.23%)

16:35
12/18/18
12/18
16:35
12/18/18
16:35
Hot Stocks
Adams Diversified Equity Fund authorizes repurchase of up to 5% of common stock »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JBL

Jabil

$22.21

0.65 (3.01%)

16:35
12/18/18
12/18
16:35
12/18/18
16:35
Hot Stocks
Jabil up 11% after Q1 results beat estimates, strong Q2 revenue guidance »

In after-hours trading,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

JCS

Communications Systems

$2.30

-0.025 (-1.08%)

16:33
12/18/18
12/18
16:33
12/18/18
16:33
Hot Stocks
Communications Systems initiates restructure »

Communications Systems,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNY

Sanofi

$43.21

-0.38 (-0.87%)

16:32
12/18/18
12/18
16:32
12/18/18
16:32
Hot Stocks
Sanofi to transfer listing to Nasdaq from NYSE »

Sanofi announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 28

    Jan

  • 11

    Mar

  • 22

    Mar

  • 28

    Apr

GNK

Genco Shipping

$7.90

0.06 (0.77%)

16:32
12/18/18
12/18
16:32
12/18/18
16:32
Hot Stocks
Genco Shipping names Robert Hughes as new COO effective January 22nd »

Genco Shipping &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAG

Conagra Brands

$28.56

-0.46 (-1.59%)

16:32
12/18/18
12/18
16:32
12/18/18
16:32
Hot Stocks
Conagra Brands to divest the Wesson oil brand »

Conagra Brands announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

JBGS

JBG Smith Properties

$36.42

0.05 (0.14%)

16:31
12/18/18
12/18
16:31
12/18/18
16:31
Hot Stocks
JBG Smith Properties declares special cash dividend of 10c per share »

JBG Smith announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLL

L3 Technologies

$184.11

-4.02 (-2.14%)

16:31
12/18/18
12/18
16:31
12/18/18
16:31
Hot Stocks
L3 Technologies awarded $350M U.S. Air Force contract »

L3 Technologies has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADMS

Adamas Pharmaceuticals

$8.11

-0.67 (-7.63%)

16:31
12/18/18
12/18
16:31
12/18/18
16:31
Hot Stocks
Adamas announces issuance of new U.S. patent covering GOCOVRI »

Adamas Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.